MIRA Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 Jun 2024 @ 16:00):
Our systems believe the stock currently is undervalued by 0.12% compare to its pairs and should correct upwards.

Stats
Today's Volume	20 173
Average Volume	119 259
Market Cap	9.42M
EPS	$-0.0872 ( Q1 \| 2024-05-13 )
Next earnings date	( $-0.100 ) 2024-09-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.970 (Sector) 42.63 (Industry) 61.14
ATR14	$0.00500 (0.78%)

CRXT -31.16%

MIRA -2.00%

SCLX 7.82%

SCLXW 5.24%

Insider Trading

Date	Person	Action	Amount	type
2024-06-18	Shekhat Denil Nanji	Buy	50 000	Nonqualified Stock Option (right to buy)
2024-05-28	Aminov Erez	Buy	379 000	Incentive Stock Options (right to buy)
2024-05-21	Aminov Erez	Buy	800	Common Stock
2024-05-21	Aminov Erez	Buy	800	Common Stock
2024-05-21	Aminov Erez	Buy	600	Common Stock

INSIDER POWER
98.88
Last 18 transactions
Buy: 1 087 700 \| Sell: 10 000

Correlation (AI algo v.1.1b): Undervalued: 0.12% $0.638 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

MIRA Pharmaceuticals, Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

MIRA Pharmaceuticals, Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-8.53M (0.00 %)
EPS:	$-0.650

FY	2023
Revenue:	$0
Gross Profit:	$-8.53M (0.00 %)
EPS:	$-0.650

FY	2022
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-0.480

Financial Reports:

No articles found.

MIRA Pharmaceuticals, Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

MIRA Pharmaceuticals,

MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog to treat anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland.